Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2023

Brain penetrance of drugs

Immunotherapy for brain cancer: Reimagining the pharmacological audit trail for drug delivery for brain tumours

Date

06 Mar 2023

Session

Brain penetrance of drugs

Topics

Clinical Research;  Immunotherapy

Tumour Site

Central Nervous System Malignancies

Presenters

Juanita Lopez

Authors

J.S. Lopez

Author affiliations

  • Drug Development Unit, The Royal Marsden Hospital NHS Foundation Trust, SM2 5PT - Sutton/GB

Resources

This content is available to ESMO members and event participants.
Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.